glp-1 receptor agonists are contraindicated in glp-1_analogs [TUSOM The Impact of GLP-1 Receptor
Description
Pharmaceutical companies are now evaluating suppliers based on: Quality management systems Regulatory readiness Manufacturing consistency Risk management capabilities Global supply chain reliability As a result, suppliers operating under recognized standards such as ISO 13485 and ISO 15378 are becoming more attractive partners for pharmaceutical developers
At the cellular level, studies suggest GLP-1 therapy may influence biological processes relevant to aging
The combination of AZD6234 with other incretin-based agents, such as the GLP-1/glucagon dual agonist AZD9550, is also being investigated in a phase 1 trial, with the planning for a phase 2 trial underway
The terminal t 1/2 of amycretin increased with increasing species size with t of 5.92 h in rats, 29.3 h in NHPs and 54.1 h in minipigs after i.v
Cureus 16 , e61783
Endocrinology 2018
